Appearance of fosfomycin resistant Rahnella aquatilis clinically isolated in Japan

Microbios

Volumn 95, Issue 381, 1998, Pages 109-115

  O'Hara, Koji ^a   Chen, Jia ^a   Shigenobu, Fritz ^a   Nakamura, Akio ^a   Taniguchi, Kazuo ^a   Shimojima, Masahiro ^b   Ida, Hiroshisa ^b   Yoshikawa, Eiji ^b   Tsuboi, Isami ^b   Mizuoka, Keiji ^b   Sawai, Tetsuo ^a  

^a CHIBA UNIVERSITY   (Japan)

^b BML   (Japan)

Author keywords

Clinical isolate; Fosfomycin; Rahnella aquatilis

Indexed keywords

ANTIINFECTIVE AGENT; F FACTOR; FOSFOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECT; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; PHENOTYPE; SERRATIA MARCESCENS; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; ENTEROBACTERIACEAE; ESCHERICHIA COLI; F FACTOR; FOSFOMYCIN; HUMANS; PHENOTYPE; SERRATIA MARCESCENS; URINARY TRACT INFECTIONS;

EID: 0032239465     PISSN: 00262633     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. ARCA P., Reguera G. and Hardisson C. 1997. Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey. J. Antimicrob. Chemother. 40 393-9.
2. BALOWS A., Hausler W. J., Herrmann K. L., Isenberg H. D. and Shadomy H. J. 1994. Manual of clinical microbiology, p 363. American Society for Microbiology, Washington, D.C., U.S.A.
3. BRYAN L. E., O'Hara K. and Wong S. 1984. Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26 250-5.
4. EDELSTEIN P. H., Edelstein M. A., Ren J., Polzer R. and Gladue R. P. 1996. Activity of trovafloxacin (CP-99, 219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia. Antimicrob. Agents Chemother. 40 314-9.
5. GARCIA P., Area P. and Suarez J. E. 1995. Product of fosC, a gene from Pseudomonas syringae, mediates fosfomycin resistance by using ATP as cosubstrate. Antimicrob. Agents Chemother. 39 1569-73.
6. INGRAM L., Sykes R. B., Grinsted J., Saunders J. R. and Richmond M. H. 1972. A transmissible resistance element from a strain of Pseudomonas aeruginosa containing no detectable extrachromosomal DNA. J. gen. Microbiol. 72 269-79.
7. IZARD D., Gavini F., Trinel P. A. and Leclerc H. 1985. Order I. Genus Rahnella. p 513. In Bergey's Manual of Systematic Bacteriology. Edited by N. R. Krieg and J. G. Holt. The Williams and Wilkins Co., Baltimore, Maryland, U.S.A.
8. KONO M. and O'Hara K. 1975. Prevalence of R factors in Pseudomonas aeruginosa. J. gen. Microbiol. 91 191-4.
9. KONO M., O'Hara K. and Shiomi Y. 1980. Nuclear magnetic resonance spectrometric assay of β-lactamase. Antimicrob. Agents Chemother. 17 16-9.
10. KUZUYAMA T., Kobayashi S., O'Hara K., Hidaka T. and Seto H. 1996. Fosfomycin monophosphate and fosfomycin diphosphate, two inactivated fosfomycin derivatives formed by gene products of fomA and fomB from a fosfomycin producing organism Streptomyces wedmorensis. J. Antibiot. 49 502-4.
11. MARTIN S. J., Pendland S. L., Chen C., Schreckenberger P. and Danziger L. H. 1996. In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella. Antimicrob. Agents Chemother. 40 1419-21.
12. MENDOZA C., Garcia J. M., Llaneza J., Mendez F. J., Hardisson D and Ortiz J. M. 1980. Plasmid-determined resistance to fosfomycin in Serratia marcescens. Antimicrob. Agents Chemother. 18 215-9.
13. O'HARA'K. 1993. Two different types of fosfomycin resistance in clinical isolates of Klebsiella pneumoniae. FEMS Microb. Letters 114 9-16.
14. O'HARA K. and Hashimoto H. 1996. Mechanism of fosfomycin resistance in clinical isolates. Jpn. J. Antibiot. 49 533-43.
15. O'HARA K., Kawabe T., Taniguchi K., Ohnuma M., Nakagawa M., Naitou Y. and Sawai T. 1997. A new simple assay for determining aminoglycoside inactivation in intact cells of Pseudomonas aeruginosa. Microbios 90 177-86.
16. O'HARA K., Kotake J., Ohmiya K. and Kono M. 1988. Fosfomycin-inactivating enzyme from clinically isolated Pseudomonas aeruginosa. Chemotherapy 36 905-10.
17. O'HARA K., Nakamura A., Shigenobu F., Chen J. and Sawai T. 1997. Combination effect of fosfomycin to β-lactam, aminoglycoside, and macrolide antibiotics against clinical isolates of Klebsiella pneumoniae. Jpn. J. Antibiot. 50 704-10.
18. O'HARA K. and Yamamoto K. 1996. Reaction of roxithromycin and clarithromycin with macrolide-inactivating enzymes from highly erythromycin-resistant Escherichia coli. Antimicrob. Agents Chemother. 40 1036-8.
19. SUAREZ J. E. and Mendoza M. C. 1991. Plasmid-encoded fosfomycin resistance. Antimicrob. Agents Chemother. 35 791-5.
20. TSUBOI I., Ida H., Yoshikawa E., Hiyoshi S., Yamaji E., Nakayama I., Nonomiya T., Sawai T. and Mizuoka K. 1998. Antibiotic susceptibility of enterohemorrnagic Escherichia coli O 157:H7 isolated from an outbreak in Japan in 1996. Antimicrob. Agents Chemother. 42 431-2.
21. VAN O. M. L. 1996. Insufficient evidence of synergistic effect of levofloxacin and rifampin against Legionella pneumophila. Antimicrob. Agents Chemother. 40 524-5.
22. VILLAR C. J., Hardisson C. and Suarez J. E. 1986. Cloning and molecular epidemiology of plasmid determined fosfomycin resistance. Antimicrob. Agents Chemother. 50 704-10.
23. ZILHAO R. and Courvalin P. 1990. Nucleotide sequence of the fosB-gene conferring fosfomycin resistance in Staphylococcus epidermidis. FEMS Microb. Letters 68 267-72.